| Product sales | 7.41B |
| Royalty revenues | |
| Contract and other revenues | |
| Total revenues | |
| Cost of goods sold | 1.13B |
| Research and development | |
| Selling, general and administrative | 831M |
| Total costs and expenses | 3.1B |
| Income from operations | 4.4B |
| Interest and other income, net | 119M |
| Interest expense | -242M |
| Income before provision for income taxes | 4.28B |
| Provision for income taxes | 951M |
| Net income | 3.33B |
| Net loss attributable to noncontrolling interest | -5M |
| Net income attributable to Gilead | 3.33B |
| Net income per share attributable to Gilead common stockholders- basic | 2.52 |
| Shares used in per share calculation - basic | 1.32B |
| Net income per share attributable to Gilead common stockholders - diluted | 2.49 |
| Shares used in per share calculation - diluted | 1.34B |